High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy

[1]  Y. Braun-Moscovici,et al.  Scleroderma overlap syndrome. , 2011, The Israel Medical Association journal : IMAJ.

[2]  W. Lehmacher,et al.  The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement , 2008, Rheumatology.

[3]  N. Hunzelmann,et al.  Immunosuppressive and antifibrotic therapy of systemic sclerosis , 2007 .

[4]  C. Denton,et al.  Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis. , 2007, Rheumatology.

[5]  Charlie Strange,et al.  Cyclophosphamide versus placebo in scleroderma lung disease. , 2006, The New England journal of medicine.

[6]  J. Pope,et al.  Scleroderma treatment differs between experts and general rheumatologists. , 2006, Arthritis and rheumatism.

[7]  M. Fritzler,et al.  A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis , 2006, Clinical Rheumatology.

[8]  E. Kasarskis.  Disease‐modifying interventions , 2004, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[9]  C. Denton,et al.  Scleroderma--clinical and pathological advances. , 2004, Best practice & research. Clinical rheumatology.

[10]  J. Pope.  Scleroderma overlap syndromes. , 2002, Current opinion in rheumatology.

[11]  N. Bellamy,et al.  A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. , 2001, Arthritis and rheumatism.

[12]  T. Medsger,et al.  Long-Term Outcomes of Scleroderma Renal Crisis , 2000, Annals of Internal Medicine.

[13]  R. Wise,et al.  Cyclophosphamide Is Associated with Pulmonary Function and Survival Benefit in Patients with Scleroderma and Alveolitis , 2000, Annals of Internal Medicine.

[14]  G. Alarcón.  Unclassified or undifferentiated connective tissue disease. , 2000, Bailliere's best practice & research. Clinical rheumatology.

[15]  T. Medsger,et al.  Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. , 2000, Arthritis and rheumatism.

[16]  Richard W. Martin,et al.  High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. , 1999, Arthritis and rheumatism.

[17]  T. Medsger,et al.  Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. , 1998, Arthritis and rheumatism.

[18]  F. V. D. van den Hoogen,et al.  Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial. , 1996, British journal of rheumatology.

[19]  P. Lachenbruch,et al.  Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. , 1995, Arthritis and rheumatism.

[20]  R. Silver,et al.  Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. , 1993, The Journal of rheumatology.

[21]  C. Brinckerhoff,et al.  Post‐Transcriptional regulationa of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts , 1992 .

[22]  R. Bennett.  Scleroderma overlap syndromes. , 1990, Rheumatic diseases clinics of North America.

[23]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[24]  M. Vatti,et al.  Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. , 1986, The Journal of rheumatology.

[25]  H. Maricq,et al.  Undifferentiated connective tissue syndromes. , 1980, Arthritis and rheumatism.

[26]  G. Rodnan,et al.  Progressive systemic sclerosis sine scleroderma. , 1962, JAMA.